Pain

Northwell Health will focus on 2 different clinical strategies for monitoring and treating severe traumatic brain injuries.

The oral CGRP antagonist becomes the first in its class approved for the indication.

In a new study, investigators examine whether a low FODMAP diet could be beneficial for patients suffering from quiescent IBD.

The approval allows Medtronic to move forward with the IN.PACT AV balloon to treat failing arteriovenous access for patients with end-stage renal disease undergoing dialysis.

The new approval grants BD the ability to move forward with a new device aimed at repairing abdominal hernias.

During AHA, investigators suggest ways to improve care for women in regard to diabetic and cardiovascular interventions.

Studies are ongoing to test the safety and efficacy of treating primary hyperoxaluria type 1 patients with lumasiran.

Todd Alexander, MD, discusses a relatively new field of nephrology research during Kidney Week.

Brad Rovin, MD, of The Ohio State University, discusses during Kidney Week what is needed for better outcomes for patients with lupus nephritis.

A new study from Northwestern is highlighting the disparities in postpartum pain management received by non-Hispanic black and Hispanic women compared to their white counterparts.

A new study has found use of ketamine for treatment of acute or chronic pain does not increase risk for hepatotoxicity or other adverse drug events, as some previous research has suggested.

The FDA is allowing Rocket Pharmaceuticals to conduct a global phase I study testing a new treatment approach for Pyruvate Kinase Deficiency.

Data from a 961-patient study shows that ustekinumab can induce and maintain remission for patients with moderate-to-severe ulcerative colitis.

With ARBs linked to a higher risk of suicide, investigators suggest treating diseases like hypertension, chronic kidney disease, heart failure, and diabetes with ACEIs instead.

In a phase 3b study, 75% of patients using HTX-011 were discharged without opioids following a total knee arthroplasty.

Recent measures in the UK has led to a drop in IBD patients using corticosteroids to excess.

In a new trial, investigators test whether continuing or discontinuing ADA is more beneficial.

The largest improvements for patients taking ustekinumab occurred following treatment every 8 weeks.

The Proclaim XR recharge-free system provides relieve through a low-dose proprietary BurstDR stimulation waveform, which mimics natural brainwave patterns that change pain signals traveling from the spinal cord to the brain.

In an intervention study, investigators try to show whether vitamin D deficiency interferes with slowing muscle wasting and losing function in geriatric adults.

At the annual meeting dedicated to heart failure, investigators present nutritional recommendations for patients, which includes dietary consultations, bariatric surgery, and a reduction in saturated fats and sodium.

There are many options to treat heart failure for patients suffering from end stage kidney disease.

In a presentation at the annual HFSA meeting, investigators compare the level of care and ultimate outcomes treating heart failure patients for cardiologists and non-cardiologists.

At the annual HFSA meeting, investigators explain how obstructed sleep apnea and central sleep apnea drive cardiovascular disease.

A pair of new mesh products will optimize hernia surgery, while reinforcing soft tissue with twice the strength.